Description
RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE
First action · last action
2015-12-31 · 2017-06-02
Transactions
2
First transaction's obligation
$300,000
Base + all options value (sum of deltas)
$263,410
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA26316D0014
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-12-31+$300,000= $300,000
- Mod P000012017-06-02-$36,590= $263,410
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-12-31 | +$300,000 | $300,000 | RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE |
| Mod P00001· CLOSE OUT | 2017-06-02 | −$36,590 | $263,410 | RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI N25KC4APTJ98)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0572 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $384,719 | FY2026 |
| 36C25225P0344 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $13,214 | FY2025 |
| 36C24924P1063 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $31,930 | FY2024 |
| 36C24724P0588 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS | $11,676 | FY2024 |
| 36C24624P0018 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $758,739 | FY2024 |
| 36C24823P2589 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $307,115 | FY2023 |
Other recipients under 6505 from 437-FARGO VA MEDICAL CENTER (00437) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26318N0404 | CSL BEHRING L.L.C. | 437-FARGO VA MEDICAL CENTER (00437) | $6,795 | FY2018 |
| 36C26318N0108 | CSL BEHRING L.L.C. | 437-FARGO VA MEDICAL CENTER (00437) | $25,553 | FY2018 |
| VA26317J1438 | CSL BEHRING L.L.C. | 437-FARGO VA MEDICAL CENTER (00437) | $6,936 | FY2018 |
| VA26317J1607 | CARDINAL HEALTH 414, LLC | 437-FARGO VA MEDICAL CENTER (00437) | $239,158 | FY2018 |
| VA26317F0994 | BAXALTA US INC. | 437-FARGO VA MEDICAL CENTER (00437) | $7,579 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26316J0243_3600_VA26316D0014_3600 · retrieved 2026-09-26.